6.68
price down icon5.25%   -0.37
after-market Dopo l'orario di chiusura: 6.68
loading
Precedente Chiudi:
$7.05
Aprire:
$7.05
Volume 24 ore:
466.58K
Relative Volume:
1.17
Capitalizzazione di mercato:
$345.28M
Reddito:
-
Utile/perdita netta:
$-19.90M
Rapporto P/E:
-12.60
EPS:
-0.53
Flusso di cassa netto:
$-19.80M
1 W Prestazione:
-4.84%
1M Prestazione:
-4.16%
6M Prestazione:
+92.51%
1 anno Prestazione:
+51.82%
Intervallo 1D:
Value
$6.65
$7.24
Intervallo di 1 settimana:
Value
$6.56
$7.24
Portata 52W:
Value
$3.19
$7.4899

Diamedica Therapeutics Inc Stock (DMAC) Company Profile

Name
Nome
Diamedica Therapeutics Inc
Name
Telefono
(763) 496-5454
Name
Indirizzo
301 CARLSON PARKWAY, MINNEAPOLIS, MN
Name
Dipendente
28
Name
Cinguettio
@diamedica
Name
Prossima data di guadagno
2025-03-17
Name
Ultimi documenti SEC
Name
DMAC's Discussions on Twitter

Confronta DMAC con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
DMAC
Diamedica Therapeutics Inc
6.68 354.07M 0 -19.90M -19.80M -0.53
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
408.61 105.69B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
481.07 61.52B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
569.17 60.69B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
837.28 50.05B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.02 35.25B 4.56B -176.77M 225.30M -1.7177

Diamedica Therapeutics Inc Stock (DMAC) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-10-07 Iniziato H.C. Wainwright Buy
2024-04-24 Ripresa Craig Hallum Buy
2023-06-22 Aggiornamento Oppenheimer Perform → Outperform
2021-04-09 Iniziato Oppenheimer Outperform
2021-02-17 Iniziato ROTH Capital Buy
2020-10-30 Iniziato Guggenheim Buy
2020-07-08 Iniziato Maxim Group Buy
2019-04-30 Iniziato Dougherty & Company Buy
2019-03-05 Iniziato Lake Street Buy
Mostra tutto

Diamedica Therapeutics Inc Borsa (DMAC) Ultime notizie

pulisher
Oct 16, 2025

Will DiaMedica Therapeutics Inc. stock reach Wall Street targetsMarket Volume Summary & Entry and Exit Point Strategies - newser.com

Oct 16, 2025
pulisher
Oct 15, 2025

Can DiaMedica Therapeutics Inc. stock outperform in 2025 bull marketJuly 2025 Volume & Fast Gaining Stock Reports - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Using economic indicators to assess DiaMedica Therapeutics Inc. potentialJuly 2025 Retail & Risk Adjusted Swing Trade Ideas - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

Will DiaMedica Therapeutics Inc. outperform the marketWeekly Trend Report & AI Powered Market Entry Strategies - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Is it too late to sell DiaMedica Therapeutics Inc.Quarterly Profit Review & Community Verified Watchlist Alerts - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

How institutional buying supports DiaMedica Therapeutics Inc. stockWatch List & High Accuracy Swing Entry Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

How hedge fund analytics apply to DiaMedica Therapeutics Inc. stockJuly 2025 Patterns & Fast Exit and Entry Strategy Plans - newser.com

Oct 13, 2025
pulisher
Oct 10, 2025

How risky is DiaMedica Therapeutics Inc. stock nowJuly 2025 Pullbacks & Daily Stock Trend Watchlist - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Is DiaMedica Therapeutics Inc. stock bottoming outJuly 2025 Opening Moves & Low Risk Entry Point Guides - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

DiaMedica Therapeutics' (DMAC) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat

Oct 10, 2025
pulisher
Oct 06, 2025

Can DiaMedica Therapeutics Inc. stock continue upward trendJuly 2025 Update & Low Drawdown Trading Techniques - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

After Golden Cross, DiaMedica Therapeutics, Inc. (DMAC)'s Technical Outlook is Bright - MSN

Oct 05, 2025
pulisher
Oct 04, 2025

Is DiaMedica Therapeutics Inc a good long term investmentHealthcare Stock Analysis & Superior Capital Growth - earlytimes.in

Oct 04, 2025
pulisher
Oct 04, 2025

DiaMedica Therapeutics (NASDAQ:DMAC) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Oct 04, 2025
pulisher
Oct 03, 2025

Will DiaMedica Therapeutics Inc. bounce back from current support2025 Market Overview & High Accuracy Swing Entry Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

DiaMedica Therapeutics Inc. stock volume spike explainedRate Cut & Daily Profit Maximizing Trade Tips - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Published on: 2025-10-03 00:24:41 - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Published on: 2025-10-02 18:46:41 - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

Perigon Wealth Management LLC Acquires Shares of 53,000 DiaMedica Therapeutics, Inc. $DMAC - MarketBeat

Oct 02, 2025
pulisher
Oct 01, 2025

Tick level data insight on DiaMedica Therapeutics Inc. volatilityJuly 2025 News Drivers & Verified Swing Trading Watchlist - newser.com

Oct 01, 2025
pulisher
Sep 29, 2025

DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Business Wire

Sep 29, 2025
pulisher
Sep 29, 2025

Published on: 2025-09-29 10:18:49 - newser.com

Sep 29, 2025
pulisher
Sep 27, 2025

What analysts say about DiaMedica Therapeutics Inc stockContrarian Investment Ideas & Free Superior Stock Performance - Early Times

Sep 27, 2025
pulisher
Sep 27, 2025

How DiaMedica Therapeutics Inc. stock reacts to oil prices2025 Winners & Losers & Daily Growth Stock Investment Tips - newser.com

Sep 27, 2025
pulisher
Sep 27, 2025

DiaMedica Therapeutics, Inc. $DMAC Shares Bought by Goldman Sachs Group Inc. - MarketBeat

Sep 27, 2025
pulisher
Sep 27, 2025

DiaMedica Therapeutics (NASDAQ:DMAC) Lowered to “Sell” Rating by Wall Street Zen - Defense World

Sep 27, 2025
pulisher
Sep 27, 2025

DiaMedica Therapeutics (NASDAQ:DMAC) Downgraded by Wall Street Zen to Sell - MarketBeat

Sep 27, 2025

Diamedica Therapeutics Inc Azioni (DMAC) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Diamedica Therapeutics Inc Azioni (DMAC) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
STAHLBERG JAN
10% Owner
Aug 13 '25
Buy
5.91
293,601
1,734,918
7,058,066
STAHLBERG JAN
10% Owner
Aug 14 '25
Buy
5.99
70,414
421,921
7,128,480
STAHLBERG JAN
10% Owner
Aug 20 '25
Buy
5.86
71,107
416,495
7,207,820
STAHLBERG JAN
10% Owner
Aug 26 '25
Buy
6.00
59,648
357,888
7,713,693
STAHLBERG JAN
10% Owner
Aug 22 '25
Buy
5.96
59,788
356,576
7,315,780
STAHLBERG JAN
10% Owner
Aug 27 '25
Buy
6.00
50,772
304,632
7,764,465
STAHLBERG JAN
10% Owner
Aug 21 '25
Buy
5.96
48,172
287,028
7,255,992
STAHLBERG JAN
10% Owner
Aug 15 '25
Buy
6.00
8,233
49,398
7,136,713
STAHLBERG JAN
10% Owner
Jul 23 '25
Buy
3.50
1,542,857
5,400,000
6,764,465
Von Koch Thomas
10% Owner
Jul 23 '25
Buy
3.50
2,857,142
9,999,997
8,383,577
$21.97
price down icon 2.96%
$87.31
price down icon 0.95%
$32.75
price up icon 0.09%
$105.08
price up icon 0.71%
$163.19
price down icon 0.21%
biotechnology ONC
$318.02
price up icon 0.59%
Capitalizzazione:     |  Volume (24 ore):